We are live on ! Find out more
ELTX icon

Elicio Therapeutics
ELTX

41 hedge funds and large institutions have $66.5M invested in Elicio Therapeutics in 2021 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.05% more ownership

Funds ownership: 1.65% → 1.7% (+0.05%)

0% more funds holding

Funds holding: 41 → 41 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

27% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 15

28% less capital invested

Capital invested by funds: $91.9M → $66.5M (-$25.4M)

Holders
41
Holders Change
–
Holders Change %
0%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
11
Reduced
15
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$2.33M
2
SCM
Stonepine Capital Management
Oregon
+$1.27M
3
HF
HRT Financial
New York
+$863K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$824K
5
BBA
BLB&B Advisors
Pennsylvania
+$820K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$7.5M
2
MWNA
Marshall Wace North America
New York
-$1.2M
3
BlackRock
BlackRock
New York
-$471K
4
ZP
Zimmer Partners
New York
-$395K
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$256K
Name Holding Trade Value Shares
Change 		Change in
Stake
E
26
Ergoteles
New York
$311K +$345K +2,392 New
CG
27
Caprock Group
Idaho
$205K – – –
Bank of America
28
Bank of America
North Carolina
$119K -$124K -862 -49%
California State Teachers Retirement System (CalSTRS)
29
California State Teachers Retirement System (CalSTRS)
California
$105K -$10.2K -71 -8%
New York State Common Retirement Fund
30
New York State Common Retirement Fund
New York
$75K +$41.1K +285 +98%
Deutsche Bank
31
Deutsche Bank
Germany
$46K -$1.59K -11 -3%
TRCT
32
Tower Research Capital (TRC)
New York
$14K +$5.19K +36 +49%
Legal & General Group
33
Legal & General Group
United Kingdom
$7K – – –
AIP
34
Ameritas Investment Partners
Nebraska
$6K – – –
Royal Bank of Canada
35
Royal Bank of Canada
Ontario, Canada
$5K -$2.31K -16 -29%
Citigroup
36
Citigroup
New York
$4K -$1.59K -11 -28%
UBS Group
37
UBS Group
Switzerland
$3K -$20.3K -141 -87%
TFA
38
Toth Financial Advisory
Virginia
$2K – – –
Wells Fargo
39
Wells Fargo
California
$1K -$26.1K -181 -95%
AIG
40
American International Group
New York
$42 -$1.88K -13 -4%
MWNA
41
Marshall Wace North America
New York
– -$1.2M -6,638 Closed
ZP
42
Zimmer Partners
New York
– -$395K -2,188 Closed
Bank of New York Mellon
43
Bank of New York Mellon
New York
– -$188K -1,042 Closed
SWM
44
Spire Wealth Management
Virginia
– -$64K -350 Closed
Bank of Montreal
45
Bank of Montreal
Ontario, Canada
– -$3K -21 Closed
TWA
46
TCI Wealth Advisors
Arizona
– +$577 +4 New
1
2

ELTX Hedge Fund Activity: Q2 2021 in Review

41 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Elicio Therapeutics (ELTX) for Q2 2021, worth a combined $66.5M — down 28% from $91.9M a quarter earlier.

Fund positioning in ELTX was balanced in Q2 2021: 5 funds opened new positions, 5 closed out, 11 added to existing stakes and 15 trimmed.

The largest buyer was BVF Inc, adding an estimated $2.33M. The largest seller was Vanguard Group, cutting an estimated $7.5M.

  • 41 institutional investors held Elicio Therapeutics (ELTX) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $66.5M of Elicio Therapeutics stock for Q2 2021, down 28% quarter-over-quarter.
  • 5 funds opened new Elicio Therapeutics positions in Q2 2021 and 5 closed out, a net change of 0 holders.
  • The largest Elicio Therapeutics buyer in Q2 2021 was BVF Inc, an estimated $2.33M added.
  • The largest Elicio Therapeutics seller in Q2 2021 was Vanguard Group, an estimated $7.5M sold.

Based on aggregated 13F filings for Q2 2021.